Recognizing the heterogeneity of DLBCL
How durable are the responses of CLL patients to therapy?
Highlights from ASH 2016: whole-genome sequencing to identify genomic lesions in ALL
An update on two trials evaluating venetoclax in subsets of CLL
Update on the clinical management of diffuse large B-cell lymphoma
Christian Gisselbrecht et al.